Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
ORIC Pharmaceuticals Inc (NASDAQ: ORIC) closed the day trading at $8.04 down -0.56% from the previous closing price of $8.09. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 5.57 million shares were traded. ORIC stock price reached its highest trading level at $8.24 during the session, while it also had its lowest trading level at $7.98.
Ratios:
For a better understanding of ORIC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.65 and its Current Ratio is at 14.65. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Evercore ISI on November 20, 2025, initiated with a Outperform rating and assigned the stock a target price of $25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’25 when Multani Pratik S sold 10,720 shares for $9.06 per share. The transaction valued at 97,129 led to the insider holds 68,149 shares of the business.
Piscitelli Dominic sold 10,720 shares of ORIC for $97,127 on Dec 16 ’25. The Chief Financial Officer now owns 68,148 shares after completing the transaction at $9.06 per share. On Dec 16 ’25, another insider, Chacko Jacob, who serves as the PRESIDENT AND CEO of the company, sold 33,374 shares for $9.06 each. As a result, the insider received 302,368 and left with 581,711 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORIC now has a Market Capitalization of 783009792 and an Enterprise Value of 503264800.
Stock Price History:
The Beta on a monthly basis for ORIC is 1.38, which has changed by -0.03481394 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, ORIC has reached a high of $14.93, while it has fallen to a 52-week low of $3.90. The 50-Day Moving Average of the stock is -31.56%, while the 200-Day Moving Average is calculated to be -14.95%.
Shares Statistics:
Over the past 3-months, ORIC traded about 1.39M shares per day on average, while over the past 10 days, ORIC traded about 1784820 shares per day. A total of 97.28M shares are outstanding, with a floating share count of 54.17M. Insiders hold about 44.29% of the company’s shares, while institutions hold 68.87% stake in the company. Shares short for ORIC as of 1764288000 were 17566525 with a Short Ratio of 12.60, compared to 1761868800 on 15494904. Therefore, it implies a Short% of Shares Outstanding of 17566525 and a Short% of Float of 18.270001.
Earnings Estimates
Currently, 13.0 analysts are dedicated to thoroughly evaluating and rating the performance of ORIC Pharmaceuticals Inc (ORIC) in the stock market.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.3 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$1.48 and -$2.41 for the fiscal current year, implying an average EPS of -$1.63. EPS for the following year is -$1.57, with 13.0 analysts recommending between -$1.22 and -$2.54.
